Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

TSLP signaling network revealed by SILAC-based phosphoproteomics.

Zhong J, Kim MS, Chaerkady R, Wu X, Huang TC, Getnet D, Mitchell CJ, Palapetta SM, Sharma J, O'Meally RN, Cole RN, Yoda A, Moritz A, Loriaux MM, Rush J, Weinstock DM, Tyner JW, Pandey A.

Mol Cell Proteomics. 2012 Jun;11(6):M112.017764. doi: 10.1074/mcp.M112.017764. Epub 2012 Feb 16.

2.

Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling.

Brown VI, Hulitt J, Fish J, Sheen C, Bruno M, Xu Q, Carroll M, Fang J, Teachey D, Grupp SA.

Cancer Res. 2007 Oct 15;67(20):9963-70.

3.

Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.

Rochman Y, Kashyap M, Robinson GW, Sakamoto K, Gomez-Rodriguez J, Wagner KU, Leonard WJ.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19455-60. doi: 10.1073/pnas.1008271107. Epub 2010 Oct 25.

4.

Quantitative phosphoproteomic analysis of IL-33-mediated signaling.

Pinto SM, Nirujogi RS, Rojas PL, Patil AH, Manda SS, Subbannayya Y, Roa JC, Chatterjee A, Prasad TS, Pandey A.

Proteomics. 2015 Jan;15(2-3):532-44. doi: 10.1002/pmic.201400303.

5.

Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction.

Isaksen DE, Baumann H, Trobridge PA, Farr AG, Levin SD, Ziegler SF.

J Immunol. 1999 Dec 1;163(11):5971-7.

6.

Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.

Levin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM, Farr AG.

J Immunol. 1999 Jan 15;162(2):677-83.

8.

TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.

Zhong J, Sharma J, Raju R, Palapetta SM, Prasad TS, Huang TC, Yoda A, Tyner JW, van Bodegom D, Weinstock DM, Ziegler SF, Pandey A.

Database (Oxford). 2014 Feb 25;2014:bau007. doi: 10.1093/database/bau007. Print 2014.

9.

Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function.

Wohlmann A, Sebastian K, Borowski A, Krause S, Friedrich K.

Biol Chem. 2010 Feb-Mar;391(2-3):181-6. doi: 10.1515/BC.2010.029.

PMID:
20128689
10.

Stable isotope metabolic labeling-based quantitative phosphoproteomic analysis of Arabidopsis mutants reveals ethylene-regulated time-dependent phosphoproteins and putative substrates of constitutive triple response 1 kinase.

Yang Z, Guo G, Zhang M, Liu CY, Hu Q, Lam H, Cheng H, Xue Y, Li J, Li N.

Mol Cell Proteomics. 2013 Dec;12(12):3559-82. doi: 10.1074/mcp.M113.031633. Epub 2013 Sep 16.

11.

Blockage of thymic stromal lymphopoietin signaling improves acute lung injury in mice by regulating pulmonary dendritic cells.

Pan G, Liang Y, Lu L, Chen X, Wang M, Wang L, Yan C, Zhang W.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10698-706. eCollection 2015.

12.

Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction.

Isaksen DE, Baumann H, Zhou B, Nivollet S, Farr AG, Levin SD, Ziegler SF.

J Immunol. 2002 Apr 1;168(7):3288-94.

13.

Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation.

Scheeren FA, van Lent AU, Nagasawa M, Weijer K, Spits H, Legrand N, Blom B.

Eur J Immunol. 2010 Apr;40(4):955-65. doi: 10.1002/eji.200939419.

14.

Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells.

Rinschen MM, Yu MJ, Wang G, Boja ES, Hoffert JD, Pisitkun T, Knepper MA.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3882-7. doi: 10.1073/pnas.0910646107. Epub 2010 Feb 5.

15.

Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

van Bodegom D, Zhong J, Kopp N, Dutta C, Kim MS, Bird L, Weigert O, Tyner J, Pandey A, Yoda A, Weinstock DM.

Blood. 2012 Oct 4;120(14):2853-63. doi: 10.1182/blood-2012-02-413252. Epub 2012 Aug 20.

16.

Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

Tasian SK, Doral MY, Borowitz MJ, Wood BL, Chen IM, Harvey RC, Gastier-Foster JM, Willman CL, Hunger SP, Mullighan CG, Loh ML.

Blood. 2012 Jul 26;120(4):833-42. doi: 10.1182/blood-2011-12-389932. Epub 2012 Jun 8.

17.

Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells.

Ali NA, Molloy MP.

Proteomics. 2011 Aug;11(16):3390-401. doi: 10.1002/pmic.201100036.

PMID:
21751366
18.

Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation.

Quentmeier H, Drexler HG, Fleckenstein D, Zaborski M, Armstrong A, Sims JE, Lyman SD.

Leukemia. 2001 Aug;15(8):1286-92.

PMID:
11480573
19.

Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patients.

Vetter T, Borowski A, Wohlmann A, Ranjan N, Kuepper M, Badura S, Ottmann OG, Friedrich K.

Leuk Res. 2016 Jan;40:38-43. doi: 10.1016/j.leukres.2015.10.003. Epub 2015 Oct 22.

PMID:
26652578
20.

Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics.

Wu X, Tian L, Li J, Zhang Y, Han V, Li Y, Xu X, Li H, Chen X, Chen J, Jin W, Xie Y, Han J, Zhong CQ.

Mol Cell Proteomics. 2012 Dec;11(12):1640-51. doi: 10.1074/mcp.M112.019091. Epub 2012 Aug 30.

Supplemental Content

Support Center